| Literature DB >> 27393135 |
Bram Brouwers1,2, Matthijs K C Hesselink1,2, Patrick Schrauwen1,2, Vera B Schrauwen-Hinderling3,4,5.
Abstract
Non-alcoholic fatty liver (NAFL) is the most common liver disorder in western society. Various factors may play a role in determining hepatic fat content, such as delivery of lipids to the liver, de novo lipogenesis, hepatic lipid oxidation, secretion of intrahepatic lipids to the circulation or a combination of these. If delivery of lipids to the liver outweighs the sum of hepatic lipid oxidation and secretion, the intrahepatic lipid (IHL) content starts to increase and NAFL may develop. NAFL is closely related to obesity and insulin resistance and a fatty liver increases the vulnerability to type 2 diabetes development. Exercise training is a cornerstone in the treatment and prevention of type 2 diabetes. There is a large body of literature describing the beneficial metabolic consequences of exercise training on skeletal muscle metabolism. Recent studies have started to investigate the effects of exercise training on liver metabolism but data is still limited. Here, first, we briefly discuss the routes by which IHL content is modulated. Second, we review whether and how these contributing routes might be modulated by long-term exercise training. Third, we focus on the effects of acute exercise on IHL metabolism, since exercise also might affect hepatic metabolism in the physically active state. This will give insight into whether the effect of exercise training on IHL could be explained by the accumulated effect of acute bouts of exercise, or whether adaptations might occur only after long-term exercise training. The primary focus of this review will be on observations made in humans. Where human data is missing, data obtained from well-accepted animal models will be used.Entities:
Keywords: Exercise; Human; Insulin sensitivity and resistance; Lipid metabolism; Non-alcoholic fatty liver disease; Prediction and prevention of type 2 diabetes; Review
Mesh:
Substances:
Year: 2016 PMID: 27393135 PMCID: PMC5016557 DOI: 10.1007/s00125-016-4037-x
Source DB: PubMed Journal: Diabetologia ISSN: 0012-186X Impact factor: 10.122
Fig. 1Pathways involved in hepatic lipid metabolism and the effect of exercise training on these pathways. Adipose tissue releases NEFA into the plasma via the process of lipolysis. Elevated fasting and postprandial plasma NEFA, originating from reduced inhibition of adipose tissue lipolysis, are taken up at the hepatic site. Fat originating from a meal is transported in chylomicrons. Adipose tissue and skeletal muscle take up fatty acids originating from the chylomicron–TAG pool via the action of LPL, while chylomicron remnants are taken up by the liver. However, when dietary fat availability is very high, the released fatty acids end up in the plasma NEFA pool via chylomicron–TAG ‘spillover’, and these NEFA can be taken up by the liver. Furthermore, hyperinsulinaemia increases hepatic glucose uptake, which activates DNL via sterol regulatory element binding protein-1 (SREBP-1), FAS and ACC. To compensate for the increased hepatic fat delivery and synthesis, hepatic TAG secretion via VLDL and hepatic TAG mitochondrial oxidation are upregulated. There is some evidence that exercise training decreases fasting and postprandial NEFA, most likely via a decrease in adipose tissue lipolysis. Moreover, exercise training increases uptake of NEFA by skeletal muscle and as a consequence lowers hepatic NEFA availability. Higher activity of LPL in skeletal muscle with exercise training increases the uptake of chylomicron–TAG by skeletal muscle, again lowering flux to the liver. In humans, exercise training lowers plasma insulin levels—a key player for activation of DNL—suggesting that exercise training might lower DNL activity, supported by animal data showing decreased ACC and FAS activity. Furthermore, animal data show that a decrease in IHL content with exercise training happens in the presence of increased PGC-1α and increased content of mitochondrial proteins used as markers of mitochondrial function (Cyt c, β-HAD and CS). Exercise training also lowers hepatic VLDL–TAG secretion, possibly as a consequence of lower hepatic TAG accumulation. Red circles represent inhibition of pathways with exercise training; green circles represent stimulation of pathways with exercise training
Main outcomes of studies that measured the effect of exercise training on IHL (measured with 1H-MRS) in humans
| Study/participant type | Training protocol | Length of intervention | Intensity of exercise training protocol | Effect on IHL | Effect on other variables |
|---|---|---|---|---|---|
| van der Heijden et al (2010) [ | |||||
| Obese Hispanic adolescents | Supervised AET ( | 12 weeks | 4×/week, 30 min; 70% of | ↓ | ↓FM, ↓VAT, ↑IS, ↓f-Ins, =f-Glu |
| Lean Hispanic adolescents | Supervised AET ( | 12 weeks | 4×/week, 30 min; 70% of | No change | =FM, =IS, =f-Ins, =f-Glu |
| Sullivan et al (2012) [ | |||||
| Obese NAFL patients | Unsupervised AET ( | 16 weeks | 5×/week, 30–60 min; 45–55% of | ↓ (vs non-exercising control) | =BW, =FM, =f-NEFA |
| Pugh et al (2014) [ | |||||
| Obese NAFL patients | Supervised AET ( | 16 weeks | 3×/week; 30 min at 30% of HRR (weeks 1–4), 30 min at 45% of HRR (weeks 5–8), 45 min at 45% of HRR (weeks 9–12), 45 min at 60% of HRR (weeks 13–16) | ↓ | ↓f-Glu, =IS, =BW, =VAT, =f-Ins |
| Lee et al (2012) [ | |||||
| Obese adolescent boys | Supervised AET | 3 months | 3×/week; 40 min at 40% of | ↓ (vs non-exercising control) | ↓BW, ↓FM, ↓VAT, =IS, =f-Glu, =f-Ins =2 h-Glu, =2 h-Ins |
| Obese adolescent boys | Supervised RET ( | 3 months | 3×/week, 60 min, 10 exercises, 2× 8–12 repetitions; 60% of 1RM (weeks 1–4), to fatigue (week 5–12) | ↓ (vs non-exercising control) | ↓BW, ↓FM, ↓VAT, ↑IS, =f-Glu, =f-Ins, =2 h-Glu, =2 h-Ins |
| Lee et al (2013) [ | |||||
| Obese adolescent girls | Supervised AET ( | 3 months | 3×/week; 40 min at 40% of | ↓ (vs non-exercising control) | ↓FM, ↓VAT, ↑IS, ↓f-Ins, =f-Glu, =2 h-Glu, =2 h-Ins |
| Obese adolescent girls | Supervised RET ( | 3 months | 3×/week, 60 min, 10 exercises, 2 × 8–12 repetitions; 60% of 1RM (weeks 1–4), to fatigue (weeks 5–12) | No change (vs non-exercising control) | ↓FM, =VAT, =IS, =f-Glu, =f-Ins, =2 h-Glu, =2 h-Ins |
| Johnson et al (2009) [ | |||||
| Obese men and women | Supervised AET ( | 4 weeks | 3×/week, 30–45 min; 50% (week 1), 60% (week 2), 70% (weeks 3 and 4) of | ↓ (vs non-exercising control) | ↓VAT, ↓f-NEFA, =BW, =f-Glu, =f-Ins |
| Hallsworth et al (2011) [ | |||||
| Men and women with NAFL | Supervised RET ( | 8 weeks | 3×/week, 8 exercises, 45–60 min; 50% (weeks 1–6), 70% (weeks 7 and 8) of 1RM | ↓ | ↑IS, ↓f-Glu, =BW, =FM, =VAT, =f-NEFA, =f-Ins |
| Finucane et al (2010) [ | |||||
| Older men and women | Supervised AET ( | 12 weeks | 3×/week, 60 min; 50% (weeks 1–4), 60% (weeks 5–8), 70% (weeks 9–12) of Wmax | ↓ (vs non-exercising control) | ↓BW, ↓f-Ins, ↓2 h-Glu, ↓2 h-Ins, =FM, =f-Glu |
| Bacchi et al (2013) [ | |||||
| Patients with type 2 diabetes and NAFL | Supervised AET ( | 4 months | 3×/week, 60 min; 60–65% HRR | ↓ | ↓FM, ↓VAT, ↑IS |
| Patients with type 2 diabetes and NAFL | Supervised RET ( | 4 months | 3×/week, 9 exercises, 3 × 10 repetitions; 70–80% of 1RM | ↓ | ↓FM, ↓VAT, ↑IS |
| Shojaee-Moradie et al (2007) [ | |||||
| Overweight healthy men | Supervised AET ( | 6 weeks | 3×/week, 20 min; 60–85% of | No change | ↑IS, ↓f-NEFA, ↓IS-NEFA, =BW, =FM |
1RM, 1 repetition maximum; 2 h-Glu, 2 h glucose (OGTT); 2 h-Ins, 2 h insulin (OGTT); AET, aerobic exercise training programme; BW, body weight; f-Glu, fasting glucose; f-Ins, fasting insulin; FM, fat mass; f-NEFA, fasting NEFA; HRR, heart rate reserve; IS, insulin sensitivity; IS-NEFA, insulin-stimulated NEFA; RET, resistance exercise training programme; VAT, visceral adipose tissue; , maximal oxygen uptake; Wmax, maximal performance
|
|
| • Increased hepatic NEFA uptake due to higher fasting and/or postprandial plasma NEFA concentrations |
| • Low partition of fatty acids to skeletal muscle (low chylomicron clearance by muscle and low NEFA uptake) |
| • Elevated DNL; activated by elevated plasma glucose and insulin concentrations |
| • Limited capacity to increase hepatic VLDL–TAG secretion and hepatic mitochondrial oxidation |
|
| |
| Plasma NEFA | • Increase in plasma NEFA uptake by skeletal muscle |
| • Some evidence for decrease in fasting and/or postprandial plasma NEFA | |
| Dietary TAG | • Increase in LPL-mediated TAG uptake by skeletal muscle |
| • Decrease in HL-mediated TAG uptake by liver | |
| DNL | • Decrease in plasma insulin, a key player for the activation of DNL |
| • In diabetes, exercise can decrease plasma glucose and hence decrease DNL | |
| • Lower ACC and FAS protein content, indicative for decreased de novo lipolysis activity (rodent data) | |
| VLDL metabolism | • Decrease in hepatic VLDL–ApoB-100 and VLDL–TAG secretion, possibly as a consequence of lower hepatic TAG accumulation |
| Mitochondrial oxidation | • Increase in hepatic CS, β-HAD and Cyt c, indicative for increases in hepatic mitochondrial content and oxidative phosphorylation (rodent data) |